Notably, previous work from our liver cancer institute demonstrated that CD73 could promote HCC progression and metastasis through activating the PI3K/AKT pathway and sustain cancer stem cell traits via stabilizing the SOX9 expression [18, 19]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.